The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here we report that mTORC2 is localized to the endoplasmic reticulum (ER) subcompartment termed mitochondria-associated ER membrane (MAM). mTORC2 localization to MAM was growth factor-stimulated, and mTORC2 at MAM interacted with the IP 3 receptor (IP3R)-Grp75voltage-dependent anion-selective channel 1 ER-mitochondrial tethering complex. mTORC2 deficiency disrupted MAM, causing mitochondrial defects including increases in mitochondrial membrane potential, ATP production, and calcium uptake. mTORC2 controlled MAM integrity and mitochondrial function via Akt mediated phosphorylation of the MAM associated proteins IP3R, Hexokinase 2, and phosphofurin acidic cluster sorting protein 2. Thus, mTORC2 is at the core of a MAM signaling hub that controls growth and metabolism.
The target of rapamycin (TOR) is a highly conserved protein kinase and a central controller of growth. Mammalian TOR complex 2 (mTORC2) regulates AGC kinase family members and is implicated in various disorders, including cancer and diabetes. Here we report that mTORC2 is localized to the endoplasmic reticulum (ER) subcompartment termed mitochondria-associated ER membrane (MAM). mTORC2 localization to MAM was growth factor-stimulated, and mTORC2 at MAM interacted with the IP 3 receptor (IP3R)-Grp75voltage-dependent anion-selective channel 1 ER-mitochondrial tethering complex. mTORC2 deficiency disrupted MAM, causing mitochondrial defects including increases in mitochondrial membrane potential, ATP production, and calcium uptake. mTORC2 controlled MAM integrity and mitochondrial function via Akt mediated phosphorylation of the MAM associated proteins IP3R, Hexokinase 2, and phosphofurin acidic cluster sorting protein 2. Thus, mTORC2 is at the core of a MAM signaling hub that controls growth and metabolism. M itochondria-associated endoplasmic reticulum (ER) membrane (MAM) is a subcompartment of the ER that forms a quasisynaptic structure with mitochondria. The main function of this membrane is to facilitate the transfer of lipids and calcium between the two organelles. MAM thereby controls mitochondrial physiology and apoptosis (1, 2) . MAM also mediates ER homeostasis and lipid biosynthesis by harboring chaperones and several key lipid synthesis enzymes (3) (4) (5) (6) . In mammalian MAM, the ER and mitochondria are physically tethered to each other by the IP 3 receptor (IP3R)-Grp75-VDAC1 (voltage-dependent anion-selective channel 1) trimeric complex (7) and by dimers of the mitofusin (Mfn) proteins Mfn1 and Mfn2 (8) (Fig. S1H ). The σ-1 receptor also stabilizes MAM by interacting with IP3R and VDAC (9) . MAM formation is regulated by multiple signaling inputs, including calcium and possibly growth factors (10) (11) (12) . However, the mechanism(s) that controls MAM formation is largely unknown other than it involves recruitment of MAM components by the MAM resident proteins phosphofurin acidic cluster sorting protein 2 (PACS2) and Rab32 (13) (14) (15) . Akt, an AGC family kinase that is also found at MAM (16) , phosphorylates PACS2 (17) , but it remains to be determined whether Akt is involved in mediating MAM integrity.
Akt, often up-regulated in cancer, also phosphorylates hexokinase 2 (HK2) to promote association of HK2 with the MAM protein VDAC1 (18, 19) . This association, possibly at MAM (20, 21) , enables HK2, using ATP exiting mitochondria through VDAC1, to phosphorylate glucose and thereby stimulate glycolysis (22) . Conversely, upon inhibition of Akt, HK2 dissociates from VDAC1, causing VDAC1 closure and increased mitochondrial membrane potential (19) . This regulation of HK2 by Akt has been proposed to account for enhanced glycolysis in cancer cells, also known as the Warburg effect (23) . Furthermore, Akt regulates calcium release from MAM by phosphorylating IP3R, thereby controlling apoptosis (24) (25) (26) . Thus, MAM is increasingly recognized as a signaling hub controlling cell physiology (15) , and is implicated in a wide spectrum of diseases, including cancer, neurodegenerative disorders, inflammation, and infection (27) .
The target of rapamycin (TOR) pathway is a cellular signaling cascade that, like mitochondria, is present in all eukaryotes (28, 29) . TOR integrates and relays signals from both extra-and intracellular sources (e.g., growth factors, nutrients, and cellular energy levels), and thereby instructs the cell to grow. TOR is found in two structurally and functionally distinct protein complexes that in mammalian cells are termed mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) (30) . mTORC2 comprises mTOR, rictor, mammalian lethal with SEC13 protein 8 (mLST8), stress-activated protein kinase (SAPK)-interacting protein (Sin1), and protor [also known as proline-rich protein 5 (PRR5)] (31) , and phosphorylates AGC kinases, such as Akt, serum/glucocorticoid-regulated kinase 1 (SGK1), and PKC, all of which are linked to cancer and diabetes (32) . Growth factors activate mTORC2 by promoting mTORC2-ribosome association in a PI3Kdependent manner (33, 34) . mTORC2 is antiapoptotic, presumably via its role in phosphorylating and activating Akt (34) (35) (36) (37) (38) .
Various observations indicate that mTORC2 is linked to both the ER and mitochondria. Recent findings suggest that mTORC2 is at the ER, possibly through interaction with ER-bound ribosomes (34, 39) . mTORC2 phosphorylates Akt at the ER (39, 40) , and mTORC2 signaling is sensitive to ER stress (41, 42) . In Chlamydomonas, TOR associates with membranes from the ER (43) . With regard to mitochondria, mTOR has been observed in close proximity to the outer mitochondrial membrane (44) , and mTOR and mLST8 interact with the mitochondrial outer-membrane protein VDAC1 (45) and the mitochondriaassociated protein Grp75 (46), respectively. mTORC2 regulates the cellular distribution of mitochondria (47) , and mTORC2activated Akt is associated with mitochondria (18, 48, 49) . Pink1, a regulator of mitochondrial function, has been implicated in mTORC2 activation (50) . mTORC2-addicted cancer cells exhibit enhanced dependence on mitochondria, Rab32 and HK2 (51) . Finally, Barquilla et al. reported that TORC2 in trypanosomes is localized to both ER and mitochondria (52) . Thus, mTORC2 has been physically and functionally linked to both the ER and mitochondria.
Here we investigate the localization of mTORC2. We show that ribosome-bound mTORC2 is at MAM. Localization to MAM is growth factor-dependent. MAM-associated mTORC2 activates Akt and thereby controls MAM integrity, mitochondrial metabolism, and cell survival. Thus, our findings describe a critical role for mTORC2 in a MAM signaling hub.
Results
mTORC2 Localizes to Mitochondria-Associated ER-Membranes. To examine mTORC2 localization, we isolated ER from mouse liver extracts by isopycnic flotation (53) . Liver was used because it is a rich source of ER and because previous studies on mTORC2 localization were performed only with cultured cells. Twenty to 60% of mTORC2 (Sin1 and rictor) was ER-associated in liver cells. mTORC1 (raptor) was not detected in the ER fraction from liver cells ( Fig. 1A) . Sin1 in the ER fraction coimmunoprecipitated with mTOR, rictor, and the ribosome, confirming that mTORC2 at the ER is intact and associated with ribosomes ( Fig. 1B) . Thus, mTORC2 appears to be localized to the ER.
To characterize further the subcellular localization of mTORC2, we analyzed rictor and Sin1 localization by indirect immunofluorescence. The mTORC2 signal overlapped with ER adjacent to mitochondria ( Fig. 1C and Fig. S1 A and B) , a staining pattern similar to that observed for MAM-localized proteins (15, 54, 55) . Controls indicating the validity of the rictor and Sin1 antibodies for immunofluorescence are presented in Fig. S1 C and D. We also detected rictor in close proximity to both the ER and mitochondria by immuno-electron microscopy (EM) on mouse liver and HEK293T cells ( Fig. 1D and Fig. S1E ). In HEK293T cells, 38% (±3.9) of rictor was adjacent to mitochondria and 48% Fig. 1 . mTORC2 is localized to MAMs. (A) mTORC2 components are present in the ER fraction of mouse livers. Total, whole cell lysate; cyto, cytoplasmic extract; ER, heavy membrane fraction from isopycnic flotation. Lysates were pooled from three different mouse livers. Mice were fed a standard chow diet and killed in the morning. Equal total protein levels were loaded in each lane. (B) mTORC2 in mouse liver ER extracts is intact and ribosome-associated. ER fraction was prepared as in A, suspended in CHAPS IP buffer and mTORC2 components were coimmunoprecipitated with Sin1. (C) ER/mito staining, reflecting colocalized ER (ER-GFP) and mitochondria (Mito-RFP), overlaps with endogenous rictor signal in U2OS cells. For individual channels, see Fig. S1A . (Scale bar, 7 μm.) Shown is maximum-intensity projection of 3D-deconvoluted, confocal image stack. Cells were grown on coverslips in normal medium before PFA fixation. (D) Representative image showing rictor (arrowheads) localization at the rough ER (electron-dense tubular structure) adjacent to a mitochondrion in a mouse liver section as detected by immuno-EM. (Scale bar, 500 nm.) (E) mTOR and rictor can be detected in crude mitochondrial extracts from mouse liver cells but not in purified mitochondrial extracts. Lysates were pooled from three different mouse livers. Mice were fed a standard chow diet and killed in the morning. Equal total protein levels were loaded in each lane. (F) Rictor (red arrowheads) is present in a purified MAM fraction as measured by immuno-EM. Rictor signal is localized to the surface of reconstituted microsomes consisting of pure MAM membranes (56) ; m, mitochondrion, copurified with MAM. (Scale bar, 500 nM.) (G) Purified MAM fraction from mouse liver extracts contains mTORC2 components but not mTORC1 component raptor. MAM markers include Rab32 and ACSL4, cytosolic marker is PGK1 mitochondrial markers are VDAC1 and Grp75, ER marker is PDI, plasma membrane marker is the insulin receptor (IR), and nuclear marker is eIF6. Lysates are pooled from three different mouse livers. 20 K and 100 K indicate fractions as described in ref. 56 . Mice were fed a standard chow diet and killed in the morning. Equal total protein levels were loaded in each lane.
(±4.7) was cytoplasmic ( Fig. S1F ). Thus, mTORC2 appears to be localized to the ER subdomain MAM.
We next examined further whether mTORC2 is MAM-associated. First, as assayed by immunoblotting of subcellular preparations, rictor was detected in a crude mitochondria fraction but not in a fraction of pure mitochondria that had been stripped of peripheral MAM (56) ( Fig. 1E ). Second, as assayed by immuno-EM on purified MAM, rictor displayed a pattern ( Fig. 1F ) similar to that observed previously for the established MAM marker phosphatidyl ethanolamine methyltransferase (PEMT)2 (57) . Third, ∼15% of total Sin1 and rictor was detected in a purified MAM fraction ( Fig.  1G ). Finally, we observed that rictor, but not the mTORC1 component raptor, coimmunoprecipitated with components of the MAM tethering complex IP3R-Grp75-VDAC1 ( Fig. S1G ). Thus, mTORC2 localizes to the ER subcompartment MAM, consistent with a recent proteomic study that identified mTOR at MAM (21) .
Localization of mTORC2 to MAM Is Stimulated by Growth Factors.
Previous studies have suggested that mTORC2 phosphorylates Akt at the ER (39, 40) . Because mTORC2 activity is insulin-PI3K stimulated, we examined whether localization of mTORC2 to MAM is regulated by growth factors. First, we observed higher levels of mTORC2 (rictor) at MAM in wild-type but not rictor knockout (KO) mouse embryonic fibroblasts (MEFs) upon insulin stimulation ( Fig. 2A ). Elevated levels of mTORC2 (rictor, Sin1) were also detected at MAM in liver extracts of mice starved overnight and refed for 2 h ( Fig. 2 B and C, and Fig. S2A ). Second, we detected enhanced interaction between mTORC2 and the MAM tethering complex IP3R-Grp75-VDAC1 after insulin stimulation ( Fig. 2D and Fig. S2B ), as assayed by coimmunoprecipitation. Finally, by immunofluorescence, we observed a significant increase in colocalization of rictor with mitochondria ( Fig. 2E and Fig. S2F ) in cells grown in the presence of serum, compared with serum-starved cells. Thus, localization of mTORC2 to MAM is stimulated by growth factors. Fig. 2 . mTORC2 localization to MAM is stimulated by growth factors. (A) mTORC2 localization to MAM is increased in insulin-stimulated control MEFs but not in MEFs in which rictor KO had been induced by addition of tamoxifen before the experiment. MEFs were starved for 6 h before the experiment and stimulated for 30 min using 100 nM insulin. MAM was isolated as before. Five confluent 15-cm plates were used as starting material for each condition. (B) mTORC2 localization to MAM is increased in livers of refed control mice, indicating that increased mTORC2 localization to MAM is also observed under physiological stimulation by food intake. Mice were starved for 14 h and refed standard diet for 2 h. Two mice were used for each fractionation. (C) Densitometric quantification of B. Protein levels were normalized to VDAC1 signal. Note that ACSL4 levels are unchanged between starved and refed status as a result of loading of equal amount of MAM. (D) mTORC2 interaction with IP3R-Grp75-VDAC1 is increased after insulin stimulation in total liver extracts from insulinstimulated control mice. Proteins were quantified relative to starved state. Mice were starved for 14 h and injected intraperitoneally with 4.5 mg/kg insulin or saline 30 min before being killed. Liver tissue was homogenized in CHAPS IP buffer. (E) Rictor colocalization (Pearson's coefficient) with mitochondria is increased in presence of serum in U2OS cells. Quantification of Fig. S2F (n = 12). (F) mTORC2, immunoprecipitated from a crude mitochondrial fraction purified from mouse liver lysates as previously, is active toward recombinant, kinase-dead Akt in an mTORC2 kinase assay. Lysates from two mice were combined for subcellular fractionation. Mice were starved for 14 h before being killed and injected intraperitoneally with 4.5 mg/kg insulin 15 min before being killed. (G) Stripping off ribosomes from crude mitochondrial extracts leads to a decrease of copurifying mTORC2 components, indicating that localization of mTORC2 to MAM depends on the presence of ribosomes. Crude mitochondrial extracts (including MAM) from HeLa cells were treated with 1 mM puromycin for 1 h and repurified. Note the decrease in the amount of ribosomes and mTORC2 but not in the mitochondrial marker VDAC1 or the MAM marker ACSL4. HeLa cells were growing in normal medium before the extraction. Results are shown as mean ± SEM and normalized to control cells. *P < 0.05, **P < 0.01. Because activation of mTORC2 involves binding to the ribosome, we examined whether mTORC2 at MAM is active and whether MAM localization of mTORC2 requires ribosome binding. First, we detected S473-phosphorylated Akt, the main read-out of mTORC2 activity, in MAM fractions ( Fig. 2A and Fig. S2A ). Second, MAM-associated mTORC2 was active against recombinant Akt in an mTORC2 kinase assay in vitro ( Fig. 2F ). Third, as judged by coimmunoprecipitation from whole-cell extracts, the interaction between mTORC2 and its substrate Akt was reduced in MAM-deficient Mfn1/2 double-KO MEFs, suggesting that MAM is an important site of mTORC2-Akt interaction ( Fig. S2 D and E) . Finally, stripping ribosomes from crude mitochondria ( Fig. 2G ) (consisting of mitochondria and MAM) reduced the amount of mTORC2 in these subcellular fractions. Ribosomes were stripped from the isolated organelles by treatment with puromycin; the stripping was thus specific for ribosomes (58) . The above observations together suggest that localization of mTORC2 to MAM and subsequent activation are dependent on growth factor signaling and interaction with the ribosome.
mTORC2 Mediates MAM Integrity. Is mTORC2 localization to MAM functionally relevant, as suggested by our above observations that mTORC2 and mTORC2-phosphorylated Akt are present at MAM ( Fig. 2A )? To answer this question, we examined whether mTORC2 is required for MAM integrity. First, we investigated the amounts of the MAM proteins IP3R and acyl CoA synthetase 4 (ACSL4) in a crude mitochondrial fraction, a technique previously established to quantify MAM (8) . The amounts of IP3R and ACSL4 were reduced in a crude mitochondrial fraction from rictor KO MEFs and livers compared with wildtype cells ( Fig. 3A and Fig. S3 A and B) , while total IP3R levels were unchanged ( Fig. S4 A and B) . As a second method to assay MAM integrity (7, 8) , we investigated the IP3R-Grp75-VDAC1 complex. Less Grp75 and VDAC1 coimmunoprecipitated with IP3R in rictor KO cells ( Fig. 3B ). Third, we quantified MAM integrity by analysis of 3D confocal images of cells coexpressing fluorescent probes for the ER and mitochondria (8, 13, 15, 54) . Rictor, Sin1, and Akt1 KO cells exhibited reduced ERmitochondrial contact ( Fig. 3D and Fig. S3 C-E). Fourth, to measure MAM at higher resolution (8, 13, 59) , we analyzed EM images of rictor KO livers ( Fig. 3C ). ER-mitochondrial contact sites were reduced ∼40% upon mTORC2 KO, although the total amounts of mitochondria and ER per cell were unchanged ( Fig.  3E ). Finally, as suggested by our above observation that insulin stimulates MAM localization of mTORC2, we found that insulin or refeeding stimulated MAM formation ( Fig. S3 B and F-H) in an mTORC2-dependent manner (Fig. 3F ). Thus, insulin signaling stimulates both localization of mTORC2 to MAM and mTORC2-dependent MAM integrity.
How does mTORC2 regulate MAM integrity? We investigated whether mTORC2 regulates MAM integrity via Akt-dependent phosphorylation of PACS2, as suggested by the observation that the Akt substrate PACS2 is required for MAM integrity (13, 17) and our previous finding that Akt1 KO affects MAM integrity ( Fig.  S3E ). First, Akt-mediated PACS2 phosphorylation was reduced in rictor knockdown cells ( Fig. 3 G and H) or in cells treated with an Akt kinase inhibitor ( Fig. 3I and Fig. S3J ). Second, PACS2 interaction with Akt at MAM was stimulated by insulin treatment (Fig. 4C and Fig. S5B ). Third, overexpression of either constitutively active Akt (Akt-S473D) or wild-type PACS2 restored MAM integrity in cells in which mTOR was pharmacologically inhibited (Fig. S3K) . Fourth, overexpression of wild-type PACS2, but not PACS2 mutated at its Akt phosphorylation site (PACS2-S437A), suppressed the defect in MAM integrity observed upon rictor knockdown ( Fig. 3J and Fig. S3I ). Thus, mTORC2 at MAM appears to control MAM integrity through Akt-dependent PACS2 phosphorylation. mTORC2 Controls Calcium Flux. Does mTORC2-Akt signaling control other processes at MAM? We investigated whether mTORC2 at MAM also controls Akt-dependent IP3R phosphorylation and function (see below for Akt target HK2). There are three IP3R isoforms, all of which contain an Akt target site (26) , but Akt inhibits ER calcium release mainly through IP3R3 (25) . We thus examined the effect of mTORC2 deficiency on phosphorylation of the Akt site specifically in IP3R3. IP3R3 phosphorylation was strongly reduced in MEFs upon rictor KO ( Fig. 4 A and B) and in HeLa cells in which mTOR was pharmacologically inhibited (Fig.  S5A ). Furthermore, the interaction between Akt and IP3R at MAM was stimulated by insulin ( Fig. 4C and Fig. S5B ) and inhibited by MAM disruption (Fig. S6 B and C) . Although IP3R levels were not affected by mTORC2 disruption (Fig. 4B and Fig.  S4 A and B) , rictor KO slightly enhanced detection of IP3R by immunoprecipitation ( Figs. 3B and 4A ). Thus, we asked whether mTORC2 masks the epitope recognized by the IP3R antibody. Using IP conditions that disrupt mTORC2, we immunoprecipitated the same amount of IP3R3 from wild-type and rictor KO cells ( Fig. S5 C and D) , confirming that intact mTORC2 masks the IP3R epitope.
Because calcium flux between the ER and mitochondria via IP3R is one of the main functions of MAM (60), we investigated whether calcium flux was disturbed in rictor KO cells. In particular, we measured changes in cytosolic calcium concentration upon stimulation with ATP or thapsigargin (TG). Importantly, we used cells suspended in calcium-free medium to rule out an effect due to influx of extracellular calcium. Like MAM-deficient cells (8, 13, 15) , rictor KO MEFs displayed an increase in intracellular calcium [Ca 2+ ] i upon either ATP or TG treatment ( Fig. 4 D and E, and Fig. S5 E-G) . Overexpression of constitutively active Akt (Akt-S473D) suppressed the enhanced TG-stimulated increase in [Ca 2+ ] i in mTORC2 KO cells ( Fig. S5 F and G) , consistent with the previous finding that active Akt inhibits IP3R-mediated calcium release (25) . Thus, mTORC2-Akt regulates IP3R3 phosphorylation and calcium release at MAM.
A previous study reported that a defect in the MAM tethering factor Mfn2 causes an increase in calcium uptake by mitochondria (8) . We examined whether a MAM deficiency caused by an mTORC2 defect elicits a similar effect. Indeed, rictor KO MEFs exhibited an increase in calcium uptake by mitochondria, as measured by a fluorescent mitochondrial calcium reporter protein ( Fig. 4F and Fig. S5H ). This finding further indicates that an mTORC2 deficiency causes a MAM defect. The above observations are counterintuitive because a reduction rather than an increase in calcium uptake by mitochondria might be expected in cells in which the ER-mitochondria synapse is disturbed. This seemingly paradoxical finding has been explained by the fact that MAM-deficient cells, possibly as a compensatory mechanism, contain larger ER calcium stores and thus release more calcium for uptake by mitochondria (8) . Accordingly, we also observed increased ER calcium stores in both mTORC2-deficient and Akt1 KO cells ( Fig. 4I and Fig. S5 I-K) and enhanced calcium release from the ER in mTORC2 KO cells ( Fig. 4 G and H) . These findings can explain the increased transfer of calcium from the ER to the mitochondria observed in mTORC2 ( Fig. 4F ) and MAM-deficient cells (8) . We conclude that the enhanced calcium release in mTORC2-deficient cells is caused by defective mTORC2-Akt signaling at MAM. In particular, the enhanced calcium release is likely because of defects in mTORC2-Akt mediated IP3R phosphorylation and MAM integrity.
mTORC2 Controls Mitochondrial Physiology. Observations described above and elsewhere (see introductory paragraphs) suggest that mTORC2, like other regulators of MAM integrity (61), affects mitochondrial function. We therefore examined whether the mitochondrial inner membrane potential (ΔΨ m ), an important indicator of mitochondrial function, is regulated by mTORC2. mTORC2 and Akt-deficient cells exhibited an increase in ΔΨ m as measured by increased tetramethylrhodamine methyl ester (TMRM) fluorescence ( Fig. 5A and Fig. S6 F-J) and ATP concentration (Fig. S6M ). The detected increase in ΔΨ m was not caused by a change in mitochondrial content (Fig. S6K ). These observations are consistent with the previous finding that rictor knockdown leads to an increase in mitochondrial respiration (62) .
How does mTORC2 control ΔΨ m ? HK2 is mitochondriaassociated and an Akt substrate (18, 19) . Phosphorylation of HK2-T473 by Akt stabilizes HK2 binding to the MAM protein VDAC1. HK2 binding to VDAC1 stimulates glycolysis and inhibits ΔΨ m (see introductory paragraphs) (18, 19) . We examined whether mTORC2 controls Akt-dependent HK2-T473 phosphorylation. HK2-T473 phosphorylation was reduced upon rictor knockdown or pharmacological inhibition of mTOR ( Fig.  5B and Fig. S6A ). Furthermore, insulin stimulated recruitment of HK2 to mitochondria, likely MAM, in an mTORC2-dependent manner ( Fig. 5 C and D) . HK2 interacted preferentially with activated Akt (Fig. S6 D and E) , and the interaction between Akt and HK2 was reduced in MAM-deficient cells ( Fig. S6 B and C) . The increase in ΔΨ m in rictor KO cells was suppressed by overexpression of activated Akt (Akt-S473D) ( Fig. S6O) or mutant HK2 containing a phosphomimetic residue at position 473 (HK2-T473D) ( Fig. 5E ). As expected, overexpression of HK2-T473A increased ΔΨ m in wild-type cells (Fig. S6L) . Interestingly, overexpression of wild-type PACS2 did not suppress the enhanced ΔΨ m caused by mTORC2 inhibition (Fig. S6I ), suggesting that the increase in ΔΨ m is independent of the defect in MAM integrity. Thus, mTORC2 at MAM controls mitochondrial physiology, at least in part, via Akt-mediated regulation of HK2.
Mitochondria play a pivotal role in apoptosis. Arachidonic acid induces apoptosis by stimulating the transfer of calcium from the ER to mitochondria at MAM (25) . Calcium release was enhanced in rictor KO MEFs upon arachidonic acid treatment, compared with wild-type MEFs (Fig. 5F ). Furthermore, an mTORC2 deficiency led to elevated levels of apoptosis ( Fig. 5 G and H). As measured by Annexin V staining, pharmacologic inhibition of mTOR ( Fig. 5I ) or disruption of mTORC2 ( Fig.  S6N ) also caused an increase in apoptosis that could be suppressed by overexpression of wild-type PACS2. These findings indicate that mTORC2 regulates apoptosis at least partly through PACS2 and MAM. Thus, mTORC2 at MAM appears to control several aspects of mitochondrial physiology (Fig. S7 ).
Discussion
We show that mTORC2 is physically associated with MAM, and that mTORC2-Akt signaling mediates MAM integrity and function. mTORC2 localizes to MAM in a growth factor-stimulated manner where it phosphorylates and activates Akt. Akt in turn phosphorylates the MAM resident proteins PACS2, IP3R, and HK2, to regulate MAM integrity, calcium flux, and energy metabolism, respectively. Accordingly, we find that mTORC2 disruption phenotypically mimics a MAM deficiency. Thus, MAM appears to be an mTORC2 signaling hub. mTORC2 is activated by association with the ribosome (34). Here we report that mTORC2 is active at MAM. Is mTORC2 at MAM activated by ribosome association? We find that mTORC2 at MAM is indeed associated with ribosomes. EM studies (59, 63, 64) and proteomic profiling (20, 21, 65) of MAM suggest that ribosomes are present at this ER subdomain. Zhang et al. (20) reported an increase in the number of ribosomes at MAM after CMV infection, a virus that is known to activate mTORC2 (66) . Finally, calnexin, a MAM-enriched chaperone (54), interacts with PACS2 and anchors ribosomes at the ER and possibly MAM (67) . Although it remains to be determined whether calnexin is indeed involved in localization of ribosomes to MAM or in mTORC2 signaling, taken together, the above data suggest that mTORC2 at MAM is activated by ribosome association.
Akt is generally thought to be localized to the plasma membrane, upon binding of its pleckstrin homology domain to phosphatidylinositol (3, 4, 5) -trisphosphate, where it is phosphorylated by phosphoinositide-dependent protein kinase-1 at T308 and by mTORC2 at S473. However, previous studies have reported active Akt at mitochondria and MAM (16, 18, 48, 49) . Furthermore, mTORC2 can phosphorylate Akt at the ER (39) and ER stress inhibits mTORC2 activity (42) , suggesting functional mTORC2-Akt signaling at the ER/MAM. Thus, there appears to be spatially distinct mTORC2 signaling pathways. Interestingly, there are at least three different versions of mTORC2, each containing a distinct Sin1 isoform (68) . mTORC2 appears to regulate MAM integrity via phosphorylation of PACS2 at S437 by Akt, because overexpression of wildtype PACS2 but not PACS2-S437A suppresses the MAM integrity defect caused by mTORC2 disruption. If phosphorylation of PACS2 at S437 is indeed mediating MAM integrity, how does overexpression of wild-type PACS2 rescue MAM integrity, even though phosphorylation of PACS2 by Akt is strongly reduced in mTORC2 deficient cells (Fig. 3F) ? We hypothesize that wildtype PACS2 can act as a multicopy suppressor, much like overexpression of SGK or Akt in worms can suppress the phenotype of a rictor KO (69) .
We report that hepatocytes from liver-specific rictor KO mice are defective for MAM. Hagiwara et al. recently reported that liver-specific rictor KO mice have whole-body metabolic defects (70) . Interestingly, liver-specific KO of Mfn2, a key MAM protein, confers a whole-body phenotype strikingly similar to that of liver-specific rictor KO (12) . Both KO mice exhibit increased gluconeogenesis, hyperinsulinemia, and glucose intolerance. This strong metabolic phenotype is consistent with the fact that the liver relies heavily on MAM function and that MAM mediates glucose metabolism (20, 57) . Furthermore, a previously reported whole-genome shRNA screen revealed that mTORC2-addicted cancer cells are dependent on mitochondrial function and in particular HK2 (51) . Thus, MAM appears to be a particularly important hub for mTORC2 signaling in the control of growth and metabolism.
In summary, we demonstrate that mTORC2 can localize to MAM, where it controls growth factor-mediated MAM integrity, calcium flux, and mitochondrial physiology. mTORC2 controls these processes via Akt which regulates PACS2, IP3R, and HK2. The combined action of these substrates affects energy metabolism and cell survival. Although the role of MAM localized mTORC2 in disease remains to be clarified, it is tempting to speculate that there could be beneficial effects of novel therapeutic interventions that specifically target mTORC2 localized to MAM.
Materials and Methods
Cell Culture. HeLa and inducible rictor knock-out MEFs were cultured, transfected, stimulated, and harvested as described previously (35, 71, 72) . Mfn1/2 KO and respective control MEFs were purchased from ATCC. For details see SI Materials and Methods.
Plasmids. GFP-tagged HK2 was kindly provided by Alenoush Vartanian (The Hospital for Sick Children, Arthur and Sonia Labatt Brain Tumor Research Centre, Toronto). HA-tagged mouse HK2 (HA-HK2) in pcDNA3.1 was kindly provided by Nobuyuki Tanaka (Department of Molecular Oncology, Graduate School of Medicine, Nippon Medical School, Tokyo) (73). HK2-T473D was generated from HA-HK2 by mutagenesis (74) using the following primers GAAGgacCTGGAGTCTCTGAAGC and CAGgtcCTTCTGGCGGGCCC. Mutagenesis was sequence verified. Adenoviral LacZ, Akt-WT and Akt-S473D were produced and used as previously described (70) . PACS2-HA and PACS2-S437A-HA (17) were obtained from Gary Thomas (Vollum Institute, Oregon Health and Science University, Portland, OR); 4mtD3cpv was kindly provided by Amy Palmer (Department of Chemistry, BioFrontiers Institute, University of Colorado, Boulder, CO) and Roger Tsien (Department of Chemistry and Biochemistry, and Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA). PACS2-Flag was purchased from Origene.
Protein Lysates, Fractionation, and Immunoprecipitation. Protein extracts were prepared as described previously (35, 71) , resolved on SDS/PAGE, and transferred to nitrocellulose membranes (Protran, Whatman). Immunoprecipitation and immunoblotting were performed as described previously (34, 35, 71) . Equal amounts for protein from different subcellular fractions were compared by immunoblotting. For details, see SI Materials and Methods.
Mice. Mice were generated as previously described (70) . All experiments were performed in accordance with federal guidelines and were approved by the Kantonales Veterinäramt of Kanton Basel-Stadt. For insulin stimulation, the mice were starved for 14-16 h overnight, then injected intraperitoneally with 4.5 mg/kg insulin or saline 30 min before being killed. Refed mice were starved for 14-16 h overnight, then refed a standard chow diet for 2 h.
Microscopy. For organelle fluorescence labeling, cells were infected 24 h before harvest with baculovirus expressing ER-GFP or Mito-RFP (BacMAM; Life Technologies). Cells were seeded on 12-mm glass slides 24 h before the experiment. For details, see SI Materials and Methods.
Statistical Analyses, Data are expressed as average ± SEM of at least three independent experiments. Unpaired t test was used to determine differences between two groups. Significance was judged when P < 0.05.
Supporting Information
Betz et al. 10 .1073/pnas.1302455110 SI Materials and Methods Cell Culture. Cells were seeded and grown for 48 h in DMEM supplemented with 10% (vol/vol) serum (basal conditions). Cells were starved of serum for 14 h unless noted otherwise before restimulation with 100 nM insulin (Sigma) for 15 min. Primary hepatocytes were isolated as previously described (6) . For mTORC2 knockdown, HeLa cells were infected with lentiviruses carrying shControl or shRictor (TRC library; Sigma Aldrich) at a multiplicity of infection of 0.1. Cells were selected after 24 h with 1 μg/mL puromycin for 1 wk, then subcloned and kept under puromycin selection. Transfection was performed using X-tremegene HD (Roche) using 1 mL Optimem (Gibco), 6 μg plasmid DNA, and 18 μL transfection reagent per 10-cm dish. Transient siRNA-mediated knockdown was performed as described previously (7) .
Protein Lysates, Fractionation, and Immunoprecipitation. Films were scanned on CanoScan 9000F and signals were quantified using densitometry functions of the FIJI application. For subfractionation, endoplasmic reticulum (ER) was isolated by isopycnic flotation using a previously described protocol (8) . Preparation of crude and pure mitochondrial extracts and mitochondriaassociated ER membrane (MAM) isolation were performed as previously published (9) . Ribosome stripping was performed as previously published (10) . Immunoprecipitation and mammalian target of rapamycin complex 2 (mTORC2) kinase assay was performed using a previously described protocol (11) . Briefly, cells were lysed on the culture plates after one washing step with cold PBS. Lysates were precleared with respective protein A or G Sepharose beads for 20 min. Lysis buffer was either CHAPS IP buffer (0.3% CHAPS, 40 mM Hepes pH7.5, 120 mM NaCl, 1 mM EDTA, 10 mM pyrophosphate, 10 mM glyerophosphate, HALT phosphatase, and protease inhibitor; Promega) or RIPA buffer (1% Triton-X, 0.1% SDS, 0.5% deoxycholate, 50 mM Tris pH 7.5, 150 mM NaCl, HALT phosphatase, and protease inhibitor; Promega), as noted, respectively. Control/mock IP was performed using equal amount of mouse/rabbit or goat IgG, respectively. mTOR complex IPs were performed for 4 h with IP antibody, followed by 1 h in the presence of protein A Sepharose beads, both steps at 4°C. Beads were washed three times in IP buffer, and loading buffer was added. IPs targeting the IP 3 receptor (IP3R) were boiled at 65°C for 25 min instead of standard 95°C for 5 min to prevent precipitation of the transmembrane proteins. To measure the phosphorylation status of IP3R, HeLa cells were starved for 14 h, treated with 500 nM PP242 or DMSO for 20 min and stimulated with 20% (vol/vol) FCS for 20 min. IP3R was immunoprecipitated and blots were probed with anti-IP3R or antiphospho-Akt-Substrate antibody. To measure the phosphorylation status of HK2, HeLa cells were transfected with HK2-HA 48 h before the experiment. HeLa cells were starved for 14 h, treated with 500 nM PP242 or DMSO for 20 min, and stimulated with 20% (vol/vol) FCS for 20 min. Blots were probed with anti-HA or antiphospho-Akt-Substrate antibody.
Microscopy. Cells were washed in PBS, fixed with 37°C 4% (vol/vol) paraformaldehyde for 2 min, washed in PBS twice, treated with 0.1% TritonX 100 for 10 min at room temperature, and blocked in 3% (wt/vol) BSA for 1 h at room temperature. For immunofluorescence, primary antibodies were added over night at 4°C (1:50 for anti-rictor, 1:200 for anti-HSP47), washed three times in PBS at room temperature, and incubated with secondary antibodies (anti-rabbit Alexa647 1:200, anti-mouse Alexa488 1:200) for 2 h at room temperature. Slides were washed three times in PBS and mounted in Mowiol mounting medium [2.4 g Mowiol 4-88; Calbiochem; 6 g glycerol, 6 mL water, 12 mL 0.2 M Trix pH8.5, 2.5% (wt/vol) (1, 4 ,-diazobicycli-[2.2.2]-octane); Sigma-Aldrich]. Fluorescence was measured on LSM510 or LSM710. Images analyzing rictor localization or ER/mitochondrial colocalization were acquired using 3D-deconvoluted stacks using the Huygens application. Colocalization (Pearson's correlation coefficient) was measured with Imaris application using automatic thresholding.
For electron microscopy, mouse liver was cut into small pieces of 1-2 mm and fixed with 0.1 M phosphate buffer containing 3% (wt/vol) formaldehyde and 0.3% glutaraldehyde for 30 min at room temperature and with fresh fixative overnight at 4°C. Then samples were washed with PBS three times for 30 min. Dehydratation was done at 4°C in 50%, 70%, 90% (vol/vol) methanol/PBS each for 1 h. Infiltration with LR gold was done according to the manufacturer's instructions (LR gold, London Resin). Polymerization was done at -10°C for 24 h. Sections of 75 nm were collected on Formvar/carbon-coated Ni-grids. Sections were stained for 15 min with 4% (wt/vol) uranyl-acetate and contrasted with lead-citrate for 60 s, visualized by a Philips EM100 electron microscope. Images were cropped for individual hepatocytes using Adobe Photoshop. Cell parameters, including ER length and mitochondrial size, were calculated using FIJI application.
Chemicals. Antibodies: mTOR, Akt, Akt pS473, Akt pT308, S6, PDI, insulin receptor, Lamp1, rictor IB, voltage-dependent anion-selective channel 1 (VDAC1), IP3R (=pan IP3R antibody), Grp75, phosphoinositide-dependent protein kinase-1, Rheb, HA, mitofusin 2 (Mfn2), RXRXXpS/T (9611), Hexokinase 2 (HK2), CoxI, cleaved Parp from Cell Signaling; Sin1, raptor, Rpl26 from Bethyl; PGK1, acyl CoA synthetase 4 (ACSL4), IP3R3 from Santa Cruz; phosphatidyl ethanolamine methyltransferase (PEMT2), rictor IF from Protein Atlas; Rab32 from Sigma; calnexin from BD Bioscience; CoxIV from Invitrogen; Hsp47 from Enzo Life Science; rictor EM from Abcam (ab104838); Rab5 antibody was obtained from Martin Spiess; rictor IP antibody was obtained from Markus Rüegg. Chemicals used were PP242 (Chemdea); insulin, ionomycin, thapsigargin and arachidonic acid (Sigma); Fura2-AM (Invitrogen).
Metabolic Measurements. Mitochondrial potential measurements were performed using MitoPT-TMRM (tetramethylrhodamine, methyl ester; ImmunoChemistry Technologies) following the manufacturers' instructions on a Bio-Rad Biomek NK; statistical analysis was performed using FlowJo 9.4. For mitochondrial Ca 2+ measurements, mouse embryonic fibroblasts (MEFs) were transiently transfected with the ratiometric cameleon probe 4mtD3cpv targeted to the mitochondrial matrix 48 h before the experiments. Ratiometric images of Ca 2+ signals were obtained using a microscope (Axio Observer, Zeiss) equipped with a Lambda DG4 illumination system (Sutter Instrument). Cells were illuminated at 440 nm (440AF21; Omega Optical) through a 455DRLP dichroic mirror, and emission was collected alternatively at 480 nm (480BP10; Omega Optical) and 535 nm (535AF26; Omega Optical), using a cooled, 12-bit CCD camera (CoolSnap HQ; Ropper Scientific). Image acquisition and analysis were performed with the Metafluor 6.3 software (Universal Imaging). Experiments were performed at room temperature in Hepes-buffered solution containing: 135 mM NaCl, 5 mM KCl, 1 mM MgCl 2 , 1 mM EGTA, 10 Hepes, 10 mM glucose, pH-adjusted at 7.45 with NaOH. For intracellular Ca 2+ measurements, cells were plated 48 h before experiment on Lab-Tek chamber slides (ThermoFisher). Chambers were washed loaded for 30 min with HBSS plus calcium, 10% (vol/vol) FCS, and 1 μM Fura2-AM (Invitrogen). Ten minutes before measurement, the medium was replaced by adding calcium-free HBSS (Sigma) and the Fura2 signal was measured as described previously (12) . The signal was captured and processed on Zeiss Cell Observer light microscope. Area under the curve (AUC) was calculated with Graphpad Prism 5 using baseline correction. Stimulations were performed with 200 μM ATP, 10 μM thapsigargin (TG), 80 μM arachidonic acid, or 10 μM ionomycin. For apoptosis measurements, Annexin V Alexa Fluor 488 (Invitrogen) measurements were performed as previously described (13) . ATP was quantified using CellTiter-Glo Luminescent assay (Promega).
Statistics. Student's t test was calculated using QuickTTestX 1.0 application. mTORC2-IP3R-Grp75 interaction is increased in total liver extracts from mice that were starved for 14 h and injected intraperitoneally with 4.5 mg/kg insulin or saline 30 min before being killed. Proteins were quantified relative to starved state. (Right) Total protein levels for Fig. 2D and panel B. (C) Rictor is hyperphosphorylated. Total proteins were extracted from mouse livers of mice that were starved for 14 h and injected intraperitoneally with 4.5 mg/kg insulin or saline 30 min before being killed. Lysates were treated with calf intestinal phosphatase (CIP; New England Biolabs) following the manufacturer's instructions. Note the band shift upon CIP treatment in rictor and Akt. (D) Immunoprecipitation of mTORC2 from total lysates of control and MAM-deficient Mfn1/2 KO MEFs. Cells were growing in normal medium before harvest and IP was performed as done previously in CHAPS IP buffer. Note that mTORC2 substrate Akt binding to mTORC2 is reduced in MAM-deficient cells, indicating that MAM is a major site of mTORC2 activity. (E) Total lysates of control and MAM-deficient Mfn1/2 KO MEFs. (F) Colocalization of rictor (green) and mitochondria (mito-RFP, red, BACMAM 2; Invitrogen), showing a diffuse localization for endogenous rictor (nucleus) upon serum starvation in U2OS cells. Quantification shown in Fig. 2E . Cells were growing on coverslips in presence or absence (14 h) of serum before fixation. (Magnification: F, 630×.) Fig. 4C . Note that starting material for IP was equalized so that equal mTORC2, IP3R, and PACS2 levels were used as input. (C) IP of IP3R3 and Sin1 from livers of rictor WT and KO mice. IP was performed either in CHAPS IP buffer, preserving mTORC2 integrity, or in RIPA buffer disrupting mTORC2. In CHAPS buffer, more IP3R3 can be precipitated in rictor KO vs. WT extracts because mTORC2 binding to IP3R3 appears to mask the epitope recognized by the IP antibody. Mice were fed a standard chow diet and killed in the morning. 
